Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Jan 31, 2025 (filed on Feb 03, 2025)Insider Name:Novo GuillermoOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:31,294Price:$64.24
-
Jan 31, 2025 (filed on Feb 03, 2025)Insider Name:Assis Alessandra FaccinOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:3,150Price:$64.00
-
Jan 23, 2025 (filed on Jan 24, 2025)Insider Name:Harrison Suzan F.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,931Price:--
-
Jan 23, 2025 (filed on Jan 24, 2025)Insider Name:Harrison Suzan F.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:1,931Price:--
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Bishop Steven DOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Harrison Suzan F.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Main SueOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Pedreiro SergioOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Peribere Jerome AOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Kulkarni Ashish KOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
Filings by filing date
-
Jan 31, 2025 (filed on Feb 03, 2025)Insider Name:Novo GuillermoOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:31,294Price:$64.24
-
Jan 31, 2025 (filed on Feb 03, 2025)Insider Name:Assis Alessandra FaccinOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:3,150Price:$64.00
-
Jan 23, 2025 (filed on Jan 24, 2025)Insider Name:Harrison Suzan F.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-1,931Price:--
-
Jan 23, 2025 (filed on Jan 24, 2025)Insider Name:Harrison Suzan F.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:1,931Price:--
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Bishop Steven DOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Harrison Suzan F.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Main SueOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Pedreiro SergioOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Peribere Jerome AOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
-
Jan 21, 2025 (filed on Jan 23, 2025)Insider Name:Kulkarni Ashish KOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,050Price:$73.16
News
Biz Brief
Sector: Basic Materials | Industry: Diversified Chemicals |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 8145 BLAZER DRIVE WILMINGTON DE 19808 |
Tel: | 1-614-7902095 |
Website: | https://www.ashland.com |
IR: | See website |
Key People | ||
Guillermo Novo Chairman of the Board, Chief Executive Officer | Eric N. Boni Principal Accounting Officer, Vice President - Finance | John Kevin Willis Chief Financial Officer, Senior Vice President |
Eileen M. Drury Chief Human Resource Officer, Senior Vice President | Osama M. Musa Senior Vice President, Chief Technology Officer | Robin E. Lampkin Senior Vice President, General Counsel, Secretary |
Alessandra Faccin Assis Senior Vice President, General Manager - Life Sciences and Intermediates | Dago Caceres Senior Vice President, General Manager - Specialty Additives | James P. Minicucci Senior Vice President, General Manager - Personal Care | Karl R Bostaph Senior Vice President - Operations |
Business Overview |
Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone. |
Financial Overview |
For the three months ended 31 December 2024, Ashland Inc revenues decreased 14% to $405M. Net loss before extraordinary items totaled $166M vs. income of $28M. Revenues reflect Life Sciences segment decrease of 33% to $134M, Specialty Additives segment decrease of 6% to $115M, Intermediates and Solvents segment decrease of 3% to $33M, North America segment decrease of 28% to $126M, Europe segment decrease of 13% to $134M. |
Employees: | 3,200 as of Dec 31, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $4,156M as of Dec 31, 2024 |
Annual revenue (TTM): | $2,046M as of Dec 31, 2024 |
EBITDA (TTM): | $613.00M as of Dec 31, 2024 |
Net annual income (TTM): | $5.00M as of Dec 31, 2024 |
Free cash flow (TTM): | N/A |
Net Debt Last Fiscal Year: | $1,094M as of Dec 31, 2024 |
Shares outstanding: | 47,182,862 as of Dec 31, 2024 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |